Are 'great' tweet­ers born? Or can they be made? A con­ver­sa­tion with Adam Feuer­stein.


If you’re a drug de­vel­op­ment pro­fes­sion­al with am­bi­tion, you can’t af­ford to ig­nore Twit­ter. No mat­ter your opin­ion of Twit­ter as a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.